President Mung Chiang joins industry leaders during SXSW to discuss the university’s role in shaping the future of pharma ...

Amgen and AstraZeneca have reported complete outcomes from the registrational Phase III WAYPOINT trial of Tezspire ...

Already billed as a potential blockbuster, Amgen and AstraZeneca’s Tezspire has turned in strong clinical data in chronic ...

The partners are building toward a regulatory submission for Tezspire in chronic rhinosinusitis with nasal polyps in the ...

Hyderabad is rapidly establishing itself as a major life sciences hub, rivaling Bengaluru, thanks to a robust state-supported ...

Amgen and AstraZeneca's Tezspire showed significant reductions in nasal polyp severity, congestion, and surgery need in CRSwNP patients in the Phase 3 WAYPOINT trial.

Amgen and AstraZeneca have announced full results from the Phase III, registrational WAYPOINT trial showing that Tezspire ...

Unlock the Secrets of AI with Expert Insights from Two Industry Leaders LUTZ, FL, UNITED STATES, March 3, 2025 /EINPresswire / -- Xraised r ...

JUPITER, Fla., March 03, 2025 (GLOBE NEWSWIRE) -- Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that Chief Executive Officer Todd Davis and Chief Financial Officer Tavo Espinoza ...

Among significant research news last week, US CNS specialist Axsome Therapeutics released new Phase III data on its recently ...

Romosozumab plus alendronate vs alendronate alone was associated with improved lumbar spine BMD in postmenopausal women with T2D.